Model
Edge
Revance Therapeutics Inc.
0001678984
Filing Type
4
Filing Date
2/4/2025
Updated
2/5/25, 5:53 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership